#United States #New York #Vascular Health #Koya Medical #Dayspring system

Koya Medical to Speak at the Stifel 2025 Healthcare Conference

Koya Medical, a pioneering player in the medtech industry, will be a feature at the Stifel 2025 Healthcare Conference scheduled for November 13, 2025. This event, located at Lotte New York Palace Hotel, will kick off at 4 PM EST. The company is recognized for its patient-centered innovations that focus on enhancing vascular health.

CEO Andy Doraiswamy is poised to deliver valuable insights into the company's ongoing clinical research, strategic growth initiatives, and the commercialization trajectory of Koya's products, including the FDA-cleared Dayspring® non-pneumatic compression system for chronic edema. This discussion aims to highlight the company's commitment to addressing critical gaps in vascular health treatment through effective and scalable solutions.

The event is designed not just for presentation but also for engagement, as attendees will have a chance to participate in one-on-one networking sessions with Koya's representatives to delve deeper into their innovative approaches in vascular care. This interaction will provide a platform for stakeholders to understand how Koya plans to influence the landscape of vascular health management.

About Koya Medical

Founded in 2018 and located in Dallas, Texas, Koya Medical is on a mission to reshape the standards of vascular care. Drawing inspiration from a personal connection to vascular issues, the company aims to bridge treatment gaps, beginning with their flagship Dayspring treatment system and extending to a comprehensive pipeline of vascular solutions that cater to the continuum of care. Koya's offerings are designed not just for clinical settings but also for at-home use, ensuring that patients receive holistic and continuous care.

The Importance of Vascular Health

Vascular diseases affect over 35 million Americans, a staggering number that showcases the pressing need for modern, evidence-based solutions. Diseases related to venous and lymphatic systems are often overlooked, leading to serious implications for patients, including impaired mobility and diminished quality of life. Koya Medical's focus on generating effective treatments embodies the urgent push required in today's healthcare ecosystem.

Looking Ahead

As Koya Medical prepares for the conference, the industry watches with interest. The future holds promises not just for Koya but for the broader community of patients requiring effective vascular care. Enhancing dialogue around these pertinent issues will ultimately lead to improved health outcomes and a more informed public regarding the challenges and solutions that exist within the realm of vascular health.

For additional information about Koya Medical and its innovative products, interested parties can visit Koya Medical's website and follow the company on LinkedIn to stay updated on their advancements in vascular health solutions.